Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- More Questions Than Answers: The Role of the Microbiome in Rheumatic Disease
-
- Anti-tumor Necrosis Factor Therapy Safety and Toxicity
- Five Important News Items From the RNS Annual Conference
- FDA Approves Biosimilar to Enbrel
- Voclosporin Meets Primary Endpoint in Lupus Nephritis Trial
- The Microbiome and Autoimmune Disease: 'Are We Not Men?'
- The Patient With Osteoarthritis
- Biosimilars Seen as Safe, Effective Compared With Reference Biologics
- Group Develops, Validates Scleroderma Body Concealment Scale
-
- Patients With SLE on Baseline Steroids may Benefit More From Belimumab
- Study: Chondroitin and Glucosamine not Superior to Placebo for Knee OA
- Weight Loss or Gain Varied by Disease-Modifying Treatment for Patients With RA
- Appropriate Equipment, Technique Ensure Accurate Placement of Joint Injections
- VIDEO: Give Patients Permission to Experience Discomfort as Part of a Safe Yoga Practice
- Speaker: Nursing Research Starts With Questions Passion and Open Mind
- Speaker: Patient Perspective is Important to Fully Assess Disease Severity
- VIDEO: Cush Addresses Management of Methotrexate Use in Patients With RA
-
- VIDEO: Develop Plan for Pregnancy in Patients With Lupus
- VIDEO: Fritz Discusses Importance of Proper Coding
- VIDEO: Ritchlin Discusses Role of Nurses in Treatment of SpA
- Aetna Warned DOJ Challenge of Humana Merger Would Result in ACA Withdrawal
- DEA Cites Lack of Safety, Abuse Potential in Rejection of Medical Marijuana
- Physicians Groups Commend FDA Biosimilar Labeling Guidance, Make Recommendations
- Similar Improvements Seen With Swimming vs Walking for Patients With Fibromyalgia